Laboratory of America Statistics
Share Statistics
Laboratory of America has 83.67M
shares outstanding. The number of shares has increased by -0.7%
in one year.
| Shares Outstanding | 83.67M |
| Shares Change (YoY) | -0.7% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 93.15% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 9 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 2.8M, so 3.35% of the outstanding
shares have been sold short.
| Short Interest | 2.8M |
| Short % of Shares Out | 3.35% |
| Short % of Float | 4.35% |
| Short Ratio (days to cover) | 3.58 |
Valuation Ratios
The PE ratio is 25.79 and the forward
PE ratio is 14.02.
Laboratory of America's PEG ratio is
0.3.
| PE Ratio | 25.79 |
| Forward PE | 14.02 |
| PS Ratio | 1.48 |
| Forward PS | 1.7 |
| PB Ratio | 2.39 |
| P/FCF Ratio | 17.56 |
| PEG Ratio | 0.3 |
Financial Ratio HistoryEnterprise Valuation
Laboratory of America has an Enterprise Value (EV) of 24.99B.
| EV / Sales | 1.92 |
| EV / EBITDA | 13.8 |
| EV / EBIT | 15.76 |
| EV / FCF | 22.81 |
Financial Position
The company has a current ratio of 1.44,
with a Debt / Equity ratio of 0.9.
| Current Ratio | 1.44 |
| Quick Ratio | 1.3 |
| Debt / Equity | 0.9 |
| Debt / EBITDA | 4.02 |
| Debt / FCF | 6.64 |
| Interest Coverage | 5.22 |
Financial Efficiency
Return on Equity is 9.26% and Return on Invested Capital is 5.21%.
| Return on Equity | 9.26% |
| Return on Assets | 4.06% |
| Return on Invested Capital | 5.21% |
| Revenue Per Employee | $213,610.84 |
| Profits Per Employee | $12,249.59 |
| Employee Count | 60,900 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 19.28 |
Taxes
| Income Tax | 212.4M |
| Effective Tax Rate | 22.14% |
Stock Price Statistics
The stock price has increased by 27.51% in the
last 52 weeks. The beta is 0.81, so Laboratory of America's
price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | 27.51% |
| 50-Day Moving Average | 235.82 |
| 200-Day Moving Average | 234.05 |
| Relative Strength Index (RSI) | 55.3 |
| Average Volume (20 Days) | 817,760 |
Income Statement
In the last 12 months, Laboratory of America had revenue of 13.01B
and earned 746M
in profits. Earnings per share was 8.89.
| Revenue | 13.01B |
| Gross Profit | 3.5B |
| Operating Income | 1.09B |
| Net Income | 746M |
| EBITDA | 1.81B |
| EBIT | 1.17B |
| Earnings Per Share (EPS) | 8.89 |
Full Income StatementBalance Sheet
The company has 1.52B in cash and 7.27B in
debt, giving a net cash position of -5.75B.
| Cash & Cash Equivalents | 1.52B |
| Total Debt | 7.27B |
| Net Cash | -5.75B |
| Retained Earnings | 8.3B |
| Total Assets | 17.6B |
| Working Capital | 1.73B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.59B
and capital expenditures -489.9M, giving a free cash flow of 1.1B.
| Operating Cash Flow | 1.59B |
| Capital Expenditures | -489.9M |
| Free Cash Flow | 1.1B |
| FCF Per Share | 13.06 |
Full Cash Flow StatementMargins
Gross margin is 26.92%, with operating and profit margins of 8.35% and 5.73%.
| Gross Margin | 26.92% |
| Operating Margin | 8.35% |
| Pretax Margin | 7.38% |
| Profit Margin | 5.73% |
| EBITDA Margin | 13.92% |
| EBIT Margin | 8.35% |
| FCF Margin | 8.42% |
Dividends & Yields
LH pays an annual dividend of $2.88,
which amounts to a dividend yield of 1.17%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 33.26% |
| Earnings Yield | 3.88% |
| FCF Yield | 5.7% |
Dividend DetailsAnalyst Forecast
The average price target for LH is $271,
which is 9.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $271 |
| Price Target Difference | 9.9% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
Stock ForecastsStock Splits
The last stock split was on Jul 3, 2023. It was a
forward
split with a ratio of 291:250.
| Last Split Date | Jul 3, 2023 |
| Split Type | forward |
| Split Ratio | 291:250 |
Scores
| Altman Z-Score | 3.1 |
| Piotroski F-Score | 8 |
